OPEN END TURBO CALL WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 01:28:40 2024-06-14 pm EDT | ||
| 0.84 EUR | 0.00% |
|
| Current month | -5.62% | ||
| 1 month | -9.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.84 | 0.00% |
| 24-06-13 | 0.84 | -1.18% |
| 24-06-12 | 0.85 | 0.00% |
| 24-06-11 | 0.85 | -3.41% |
| 24-06-10 | 0.88 | -3.30% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 01:28 pm EDT
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH2CNK |
| ISIN | DE000UH2CNK0 |
| Date issued | 2021-09-03 |
| Strike | 208.6 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.14 € |
|---|---|
| Lowest since issue | 0.12 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
